Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Seclidemstat (mesylate)

Product Specifications

UNSPSC Description

Seclidemstat (SP-2577) mesylate is a potent noncompetitive and reversible KDM1A (LSD1) inhibitor (Ki=31 nM, IC50=13 nM). Seclidemstat mesylate promotes antitumor immunity in switch/sucrose nonfermentable (SWI/SNF) complex mutated ovarian cancer, as well as inhibit virus production, viral DNA replication, and late gene expression. Seclidemstat mesylate can be used for the research of Ewing Sarcoma[1][2].

Target Antigen

Histone Demethylase

Type

Reference compound

Related Pathways

Epigenetics

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/seclidemstat-mesylate.html

Purity

99.60

Solubility

DMSO : 53.33 mg/mL (ultrasonic)|H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C)

Smiles

O=C(N/N=C(C1=CC(Cl)=CC=C1O)\C)C2=CC=CC(S(=O)(N3CCN(C)CC3)=O)=C2.CS(O)(=O)=O

Molecular Weight

547.04

References & Citations

[1]Dai XJ, et al. Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1 [published correction appears in J Med Chem. 2021 May 13;64(9):6410-6411]. J Med Chem. 2021;64(5):2466-2488. |[2]Soldi R, et al. The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer. PLoS One. 2020;15(7):e0235705. Published 2020 Jul 10. bioRxiv. 2024 October 29.|ACS Pharmacol Transl Sci. November 12, 2021.|bioRxiv. 2020 May.|Cancer Lett. 2024 Aug 21:600:217182.|Mol Divers. 2024 Mar 24.|Nat Cell Biol. 2022 Feb 17.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture and light)

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-103713A/Seclidemstat-mesylate-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-103713A/Seclidemstat-mesylate-SDS-MedChemExpress.pdf

Clinical Information

Phase 2

CAS Number

2044953-70-8

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

LMNA Antibody
CSB-PA013003GA01HU 100 µL

LMNA Antibody

Ask
View Details
Mtmr2 Rat shRNA Lentiviral Particle (Locus ID 315422)
TL706667V 500 µL Each

Mtmr2 Rat shRNA Lentiviral Particle (Locus ID 315422)

Ask
View Details
KIAA0195 (TMEM94) (NM_014738) Human Tagged Lenti ORF Clone
RC208451L2 10 µg

KIAA0195 (TMEM94) (NM_014738) Human Tagged Lenti ORF Clone

Ask
View Details
mmu-miR-7679-3p miRNA Antagomir
MBS8320351-01 10 nmol

mmu-miR-7679-3p miRNA Antagomir

Ask
View Details
mmu-miR-7679-3p miRNA Antagomir
MBS8320351-02 20 nmol

mmu-miR-7679-3p miRNA Antagomir

Ask
View Details
mmu-miR-7679-3p miRNA Antagomir
MBS8320351-03 5x 20 nmol

mmu-miR-7679-3p miRNA Antagomir

Ask
View Details